Neuropsychopharmacology Research
Selected research projects and clinical studies in neuropsychopharmacology, CNS mechanisms, and treatment modalities.
A comprehensive clinical‑pharmacology review analyzing mechanisms of sleep regulation, pharmacological classes used for insomnia, and the availability of modern treatments including novel orexin antagonists within the UAE.
View Full Study →Clinical evaluation of Spravato (Esketamine), an NMDA receptor antagonist, in patients with major depressive disorder or treatment‑resistant depression who did not respond to standard therapies.
View Full Study →Sleep architecture, orexin signaling, hypnotic mechanisms, and circadian‑aligned interventions.
Major depression mechanisms, NMDA receptor modulation, and novel antidepressant pathways.
Ligand‑receptor interactions, downstream signaling, and predictive receptor modeling.
Evidence‑based healthcare in the UAE and Middle East region, treatment availability analysis.